Targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: Conventional and novel approaches
The therapy of inflammatory bowel diseases can be improved by development of new effective and selective biological drugs and efficiency improvement of existing, traditional anti-inflammatory drugs via targeting sites of inflammation. Targeted drug delivery upon peroral administration results in imp...
Main Authors: | Čalija Bojan, Milić Jela |
---|---|
Format: | Article |
Language: | srp |
Published: |
Pharmaceutical Association of Serbia, Belgrade, Serbia
2017-01-01
|
Series: | Arhiv za farmaciju |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2017/0004-19631702124C.pdf |
Similar Items
-
An oral delivery vehicle based on konjac glucomannan acetate targeting the colon for inflammatory bowel disease therapy
by: Chuang Wang, et al.
Published: (2022-11-01) -
New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy
by: Adrian H. Teruel, et al.
Published: (2020-09-01) -
An Orally Administrated Hyaluronan Functionalized Polymeric Hybrid Nanoparticle System for Colon-Specific Drug Delivery
by: Niranjan G. Kotla, et al.
Published: (2019-09-01) -
Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease
by: Yilin Guo, et al.
Published: (2018-07-01) -
Orally administered liposomal formulations for colon targeted drug delivery
by: Susan eHua
Published: (2014-06-01)